110
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures

, , , , &
Pages 1355-1361 | Accepted 18 Jul 2005, Published online: 29 Jul 2005

References

  • van Staa TP, Dennison EM, Leufkens HG et al. Epidemiology of fractures in England and Wales. Bone 2001;29:517–22
  • Eastell R, Reid DM, Compston J et al. Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? Q J Med 2001;94:575–97
  • Burge RT, Worley D, Johansen A et al. The cost of osteoporotic fractures in the UK: Projections for 2000–2020. J Med Econ 2001;4:51–62
  • McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The Fracture Liaison Service: Success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporosis Int 2003;14:1028–34
  • MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536–8
  • Tsai K-S, Heath H III, Kumar R et al. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest 1984;73:1668–72
  • Heaney RP, Dowell MS, Hale CA et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142–6
  • Gallagher JC, Jerpbak CM, Jee WSS et al. 1,25-Dihydroxyvitamin D3: Short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USA 1982;79:3325–9
  • Holick MF, Siris ES, Binkley N et al. Vitamin D inadequacy is highly prevalent among North American women treated for osteoporosis. Poster presented at the American Society for Bone Mineral Research annual meeting, Seattle, October 2004
  • Singh SK, Manjure S, Stott P et al. Does routine blood bone biochemistry predict vitamin D insufficiency in elderly patients with low-velocity fractures? J Orthop Surg 2004;12:31–4
  • Department of Health. Nutrition and bone health: with particular reference to calcium and vitamin D. Report on Health and Social Subjects 49. London, Department of Health, 1998
  • Barragry JM, France MW, Corless D et al. Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin Sci Mol Med 1978;55:213–20
  • Finch S, Doyle W, Lowe C et al. National diet and nutrition survey: people aged 65 years and over. London, HMSO, 1998
  • LeBoff MS, Kohlmeier L, Hurwitz S et al. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999;281:1505–11
  • Blau EM, Brenneman SK, Bruning AL et al. Prevalence of vitamin D inadequacy in an osteoporosis population in Southern California. Poster presented at the American Society for Bone Mineral Research annual meeting, Seattle, October 2004
  • Simonelli C, Morancey JA, Swanson L et al. A high prevalence of vitamin D inadequacy in a minimal trauma fracture population. Poster presented at the American Society for Bone Mineral Research annual meeting, Seattle, October 2004
  • Sidwell AI, Wilkinson TJ, Hanger HC. Secondary prevention of fractures in older people: evaluation of a protocol for the investigation and treatment of osteoporosis. Intern Med J 2004;34:129–32
  • Wong PKK, Spencer DG, McElduff P et al. Secondary screening for osteoporosis in patients admitted with minimal-trauma fracture to a major teaching hospital. Intern Med J 2003;33:505–10
  • National Institute for Clinical Excellence. Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. January 2005
  • British Orthopaedic Association. The care of fragility fracture patients. September 2003
  • Dawson Hughes B, Heaney RP, Holick HF et al. Estimates of optimal vitamin D status. Osteoporos Int 2005:16;713–6
  • Holick MF. The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002;9:97–8
  • Heaney RP. Vitamin D: How much do we need, and how much is too much? Osteopor Int 2000;11:553–5
  • Hosking D, Lippuner K, Turpin J et al. An international study of the prevalence of vitamin D inadequacy among community dwelling women with osteoporosis. Poster presented at Fifth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Rome, March 2005
  • Vasant Hirani, personal communication
  • National Center for Health Statistics. Third National Health and Nutrition Examination Survey (NHANES III 1988–1994). Hyattsville, Maryland: Public Health Service, 1996
  • Looker AC, Dawson-Hughes B, Calvo MS, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002;30:771–7
  • Blumsohn A, Naylor KE, Timm W et al. Absence of marked seasonal change in bone turnover: A longitudinal and multicenter cross-sectional study. J Bone Miner Res 2003;18:1274–81
  • Pasco JA, Henry MJ, Kotowicz MA et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004;19:752–8
  • Kanis JA, Johnell O, De Laet C et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 2002;17:1237–44
  • Schwartz AV, Kelsey JL, Maggi S, et al. International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int 1999;9:242–53
  • Icelandic Osteoporosis Society. Available from: www.beinvernd.is/enska.htm [Last accessed 1 June 2005]
  • Glendenning P, Noble JM, Taranto M et al. Issues of methodology, standardisation and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassy and the Nichols Advantage automated chemiluminescence protein binding assay in hip fracture cases. Ann Clin Bichem 2003;40:546–51
  • Zerwekh JE. The measurement of vitamin D: analytical aspects. Ann Clin Biochem 2004;41:272–81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.